8th April 2021 Product update: new protein staff writer
New Animal-Free Solutions Join the Molecular Farming Revolution
Moolec Science, a molecular farming company, has announced it will expand its meat-focused portfolio for alternative proteins with the development of egg replacements and the expansion of its dairy offer, further increasing the range of its integral animal-free food solutions.
"We started exploring the space more than 10 years ago. We were the first team to fully deregulate a Molecular Farming crop and its functionalized protein concentrate for its use in the cheese-making industry, a product that has been successfully used in the manufacturing of thousands of tons of soft and hard cheeses. Since then, we expanded to animal-free meat ingredients and are now announcing a broadening of our pipeline into dairy and egg replacements," said Gastón Paladini, CEO & CO-Founder.
Moolec presents its latest two developments for the new food industry. Leveraging the increasing utilization of oat protein in the alternative dairy space, the Company is functionalizing oat concentrates with co-expressed whey protein.
Similarly, ovum protein is being engineered into wheat for an egg replacement specially designed for the bakery industry. These products will both join the meat analogs currently in Moolec's pipeline, blends of soybean with selected porcine proteins and pea with bovine proteins to complete the Company's growing portfolio.
"Our selection of dairy and egg proteins will be produced in the host crop. We are going to let the plants, the sun, and the land work, and, after only basic processing, Moolec's product will have superior nutritional and functional properties for a fraction of the cost. For example, our wheat and egg protein products will have a higher content of digestible protein and, thus, improved nutritional value," said Henk Hoogenkamp, CPO & Co-Founder.
Moolec recently acquired a nutritional oil technology for the production of gamma-linolenic acid (aka GLA, branded SONOVA®). This technology complements the Company's bovine chymosin production platform, both of which are based in the safflower crop, resulting in significant efficiencies.
For further details, please use the 'Request Information' button provided below.
Date Published: 8th April 2021
Source article link: View
Note: This content has been edited by a newprotein.net staff writer for style and content.